Ariel Hanson

Ariel Hanson has a diverse work experience in the field of biotechnology and regenerative medicine. Ariel has held various roles in different companies, starting with their current position as the Director of Program Management at C4 Therapeutics, Inc. Their previous role was as the Associate Director of Program Management at Rubius Therapeutics, where they provided support for both pre-clinical and clinical trial teams. Prior to that, Ariel worked at Genuity Science as a Senior Program Manager and Strategic Alliance Manager, where they were responsible for project execution and managing relationships with collaborative institutions. Ariel also worked as a Project Specialist and Research Scientist at Biostage, Inc., where they gained experience in project management and molecular characterization of stem cells. Ariel's earlier experience includes working as a Scientific Consultant at AmnioLife Corporation and as a Postdoctoral Fellow and Research Associate at the University of North Carolina at Chapel Hill. Ariel also served as a Staff Scientist at Plureon Corporation and as a Research Associate at the Joint Department of Biomedical Engineering at the UNC-Chapel Hill and NCSU, where they specialized in microfluidic devices and stem cell differentiation.

Ariel Hanson's education history begins with their attendance at Central Bucks High School West, although precise dates are not provided. Following their high school education, they pursued a Bachelor of Science degree in Mechanical Engineering at Northeastern University from 1999 to 2004. They then furthered their studies by obtaining a Master of Science degree in Biomedical Engineering at North Carolina State University from 2004 to 2007. Lastly, Ariel completed their education journey by earning a PhD in Biomedical Engineering from the University of North Carolina at Chapel Hill, spanning from 2010 to 2015.